These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35567896)

  • 1. Nanotechnology and tuberculosis: An old disease with new treatment strategies.
    Macêdo DCDS; Cavalcanti IDL; Medeiros SMFRDS; Souza JB; Lira Nogueira MCB; Cavalcanti IMF
    Tuberculosis (Edinb); 2022 Jul; 135():102208. PubMed ID: 35567896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in nanotechnology for diagnosis and treatment of tuberculosis.
    Banyal S; Malik P; Tuli HS; Mukherjee TK
    Curr Opin Pulm Med; 2013 May; 19(3):289-97. PubMed ID: 23429097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-Based Drug Delivery Systems for Treatment of Tuberculosis--A Review.
    da Silva PB; de Freitas ES; Bernegossi J; Gonçalez ML; Sato MR; Leite CQ; Pavan FR; Chorilli M
    J Biomed Nanotechnol; 2016 Feb; 12(2):241-60. PubMed ID: 27305759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current nanotechnological strategies using lipids, carbohydrates, proteins and metal conjugates-based carrier systems for diagnosis and treatment of tuberculosis - A review.
    Usharani N; Kanth SV; Saravanan N
    Int J Biol Macromol; 2023 Feb; 227():262-272. PubMed ID: 36521715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.
    Grotz E; Tateosian N; Amiano N; Cagel M; Bernabeu E; Chiappetta DA; Moretton MA
    Pharm Res; 2018 Sep; 35(11):213. PubMed ID: 30238168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy.
    Beg S; Saini S; Imam SS; Rahman M; Swain S; Hasnain MS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):85-94. PubMed ID: 28480833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and Innovative Approach of Nanotechnology with their Applications in the Management of Infectious Disease, Tuberculosis: An Overview.
    Singh S; Ahuja A
    Recent Pat Nanotechnol; 2024; 18(2):140-163. PubMed ID: 35616678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-based drug delivery optimization for tuberculosis treatment: A review.
    Dahanayake MH; Jayasundera ACA
    J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches for designing and delivering solid lipid nanoparticles of distinct antitubercular drugs.
    Vasam M; Goulikar RK
    J Biomater Sci Polym Ed; 2023 Apr; 34(6):828-843. PubMed ID: 36341573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis.
    Kia P; Ruman U; Pratiwi AR; Hussein MZ
    Int J Nanomedicine; 2023; 18():1159-1191. PubMed ID: 36919095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease.
    Biswas B; Misra TK; Ray D; Majumder T; Bandyopadhyay TK; Bhowmick TK
    Int J Pharm; 2023 Jun; 640():123018. PubMed ID: 37149113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.
    Andrade F; Rafael D; Videira M; Ferreira D; Sosnik A; Sarmento B
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1816-27. PubMed ID: 23932923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-Drug Delivery Systems: Possible End to the Rising Threats of Tuberculosis.
    Sheikh BA; Bhat BA; Alshehri B; Mir RA; Mir WR; Parry ZA; Mir MA
    J Biomed Nanotechnol; 2021 Dec; 17(12):2298-2318. PubMed ID: 34974855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis.
    Kaur M; Garg T; Rath G; Goyal AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):49-88. PubMed ID: 24579767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis.
    Rath G; Pradhan D; Ghosh G; Goyal AK
    Curr Pharm Des; 2021; 27(17):2026-2040. PubMed ID: 33634753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities.
    Patil K; Bagade S; Bonde S; Sharma S; Saraogi G
    Biomed Pharmacother; 2018 Mar; 99():735-745. PubMed ID: 29710471
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.